Rivas A, Ruegg CL, Zeitung J et al. (1995). "V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.". J. Immunol.154 (9): 4423–33. PMID7722299.CS1 maint: Explicit use of et al. (link)
Ruegg CL, Rivas A, Madani ND et al. (1995). "V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene.". J. Immunol.154 (9): 4434–43. PMID7722300.CS1 maint: Explicit use of et al. (link)
Soares LR, Rivas A, Tsavaler L, Engleman EG (1997). "Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.". J. Immunol.159 (3): 1115–24. PMID9233604.
Soares LR, Tsavaler L, Rivas A, Engleman EG (1998). "V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocation.". J. Immunol.161 (1): 209–17. PMID9647226.
Stipp CS, Kolesnikova TV, Hemler ME (2001). "EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.". J. Biol. Chem.276 (44): 40545–54. doi:10.1074/jbc.M107338200. PMID11504738.